Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain
the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in
Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles
The first patient has been dosed with a base editor — the latest genome-editing technology to enter the clinic — and other trials are set to start soon. These therapeutics are designed to permanently change a single letter in a patient’s genetic code at a specific location, providing new opportunities to silence, mend, modulate and upregulate genes.